• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

TargetRx to Keynote at 5th Annual Pharmaceutical Product Launches Summit

Posted on: Wednesday, 29 November 2006, 09:00 CST

TargetRx President and CEO Mike Luby will deliver the keynote address at the upcoming 5th Annual Pharmaceutical Product Launches Summit, to be held December 5-6, 2006. As a keynote presenter, Luby will discuss the actions a company should take prior to the launch of a new drug in order to maximize brand opportunities.

This conference will feature both pharmaceutical and biotech executives from companies such as AstraZeneca and Endo Pharmaceuticals, who will discuss how pharmaceutical, biotech and specialty pharmas prosper by bringing new drugs to market. The program will cover the latest issues facing product launch teams, including launch readiness, maximizing ROI, pre-launch reimbursement, global launch success and co-promotional launch tactics.

CBI's 5th Annual Pharmaceutical Product Launches Summit December 5-6, West Conshohocken, Pa. Conference Co-chair Keynote Address: "Predictive Power: Higher Standards for Product Launches Bring New Strategies for Success," Tuesday, December 5, 2006, 2:05-2:35 p.m.

In addition to serving as the conference co-chair, Luby's keynote address will discuss how new products play an extremely critical role in the health of the pharmaceutical industry and what can be done to improve product launches. With competition rising and so much riding on the success of each launch, the tools to help pharmaceutical companies execute a successful launch should be well-oiled machines - but this couldn't be further from the truth. Currently, there is no standard of information to evaluate:

- Achievable opportunity for a brand post-launch, - A brand's readiness to capture that opportunity, or - The actions to take prior to launch to ensure greater launch success.

However, this knowledge can be gained by tracking critical factors such as physician awareness, knowledge of the launch product, perceptions relative to other products, how the product addresses unmet needs in the marketplace and anticipated usage of the product when launched. Luby's session will describe both the need and opportunity for pharmaceutical companies to improve the effectiveness of new product launches, minimizing the risks of under-performance and increasing the opportunities for success.

For more information or to register for this event, visit: http://www.cbinet.com/show_conference.cfm?confCode=HB671.

About TargetRx

TargetRx is a pharmaceutical sales and marketing effectiveness company that provides actionable insight to pharmaceutical companies to help them effectively sell and market their products and improve their financial performance. TargetRx has developed a highly predictive, database of physician attitudes that it uses in combination with its patented analytic methods to provide pharmaceutical companies with powerful "leading indicators" of how their sales and marketing initiatives will affect physician prescribing. TargetRx benchmarks performance, identifies immediate improvement opportunities and predicts future performance for its clients. TargetRx works with the majority of the top 30 pharmaceutical companies in the U.S. For further information, visit www.targetrx.com.

Source: Business Wire

More News in this Category